Symbios Orthopédie SA
Agnès Davy has extensive experience in regulatory affairs in various medical fields such as hip and knee joint replacement implants, contrast media injection for CT and MRI imaging, population health management, sleep diagnostics, and retinal oximetry. With a background in biomedical engineering, Agnès has managed regulatory activities for product design, development, and market placement, as well as provided regulatory consultancy to medical device manufacturers. Agnès's roles have included managing change control processes, labeling requirements, regulatory pre-market and post-market activities, and quality management systems implementation. Agnès has also gained experience in supporting pre-sales activities, installations, and research projects in the healthcare industry.
Symbios Orthopédie SA
Symbios is a Swiss medical technology company, and the leader in custom-made orthopaedic implants for hip and knee joint replacement. It was founded in 1989 by Jean Plé and two associates, including an orthopedic surgeon. Their vision was to design and manufacture custom-made implants that adapt perfectly to each patient’s individual anatomy. As there are as many different body shapes as there are patients, a custom-made implant is above all a unique implant for a unique patient, designed to better restore mobility and satisfaction. Since its creation and based today on 30 years of experience, Symbios has pioneered and constantly improved the technology of custom implant manufacturing, thus becoming the company with the greatest expertise in this field worldwide. In addition to providing products that are better adapted to patients, customization of implants enables a major breakthrough in today’s orthopedic supply model, allowing for a significant reduction in stocks and instruments for healthcare facilities. The cost of healthcare linked to changing demographics is a growing concern, and we believe that this is the ultimate way to maximize the efficiency of healthcare facilitiesand enable them to reduce operational costs in the future, while improving the quality of care.